Drug Shortage Report for AZARGA
| Report ID | 54440 |
| Drug Identification Number | 02331624 |
| Brand name | AZARGA |
| Common or Proper name | AZARGA OPH SUSP 5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TIMOLOL BRINZOLAMIDE |
| Strength(s) | 0.5% 1.0% |
| Dosage form(s) | SUSPENSION |
| Route of administration | OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01ED |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-06-25 |
| Estimated end date | 2018-07-25 |
| Actual end date | 2018-07-25 |
| Shortage status | Resolved |
| Updated date | 2018-07-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-07-05 | English | Compare |
| v2 | 2018-07-05 | French | Compare |
| v3 | 2018-07-11 | English | Compare |
| v4 | 2018-07-11 | French | Compare |
| v5 | 2018-07-20 | English | Compare |
| v6 | 2018-07-20 | French | Compare |
| v7 | 2018-07-27 | English | Compare |
| v8 | 2018-07-27 | French | Compare |
Showing 1 to 8 of 8